Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives

The present antipsychotic drugs have known to show serious concerns like extra pyramidal side effects therefore, pursuit for novel antipsychotic GABAnergic drugs has lately focused on the folkloric medicine from plant derivatives as better treatment option of schizophrenia. The present study centers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioinformation 2015-01, Vol.11 (6), p.280-289
Hauptverfasser: Sahila, Mohammed Marunnan, Babitha, Pallikkara Pulikkal, Bandaru, Srinivas, Nayarisseri, Anuraj, Doss, Victor Arokia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 289
container_issue 6
container_start_page 280
container_title Bioinformation
container_volume 11
creator Sahila, Mohammed Marunnan
Babitha, Pallikkara Pulikkal
Bandaru, Srinivas
Nayarisseri, Anuraj
Doss, Victor Arokia
description The present antipsychotic drugs have known to show serious concerns like extra pyramidal side effects therefore, pursuit for novel antipsychotic GABAnergic drugs has lately focused on the folkloric medicine from plant derivatives as better treatment option of schizophrenia. The present study centers to identify potential inhibitors of plant origin for GABA receptor through in silico approaches. Three compound datasets were undertaken in the study. The first set consisted of seven compounds which included Magnolol, Honokiol and other plant derivatives. The second set consisted of 16 derivatives of N-diarylalkenyl-piperidinecarboxylic acid synthesized by Zheng et al., 2006. The third dataset had thirty two compounds which were Magnolol and Honokiol analogues synthesized by Fuchs et al., 2014. All the compounds were docked at the allosteric site of the GABA (A) receptor. The compounds were further tested for ADMET and biological activity. We observed Honokiol and its derivatives demonstrated superior druglike properties than any compound undertaken in the study. Further, compound 61 [2-(4-methoxyphenyl)-4-propylphenol] of dataset three - a synthetic derivative of honokiol had better profile than its parent compound. In a possible attempt to identify compound with even better efficacious compound than 61, virtual screening was performed, 135 compounds akin to compound 61 were retrieved. Interestingly none of the 135 compounds showed better druggable properties than compound 61. Our in silico pharmacological profiling of compounds is in coherence and is complemented by the findings of Fuchs et al, which also revealed compound 61 to be the good potentiator of GABA receptor. GABA (A) R - Gamma Amino Butyric Acid Receptor, subtype A, GPCR - G Protein Coupled Receptor, OPLS - Optimized Potentials for Liquid Simulations, PDB - Protein Data Bank, PLP - Piece wise Linear Potential, T.E.S.T - Toxicity Estimation Software Tool, TCM - Traditional Chinese Medicine.
doi_str_mv 10.6026/97320630011280
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4512002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1701346548</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-5b8403ff62da8b4438a0de0d030aa2571d7d8fd9af23f4f2a6b158fee56ceac63</originalsourceid><addsrcrecordid>eNqNUctKBDEQDKL4vnqUHPWw2kkmmexFWMUXKF4UvIVM0tHo7GRNZhf8e2fxgd48dXV3ddFFEbLH4EgBV8fjWnBQAoAxrmGFbMIwGS1Hq7_wBtkq5QWgYnUt18kGV5yPudab5PE2tejmrc3UJ_cauyfa2IKeFpcRu2WfAr2cnE7oweSQZnQ461OmsXuOTRxQoSGnKZ21tuupxxwXto8LLDtkLdi24O5X3SYPF-f3Z1ejm7vL67PJzcgJKfqRbHQFIgTFvdVNVQltwSN4EGAtlzXztdfBj23gIlSBW9UwqQOiVA6tU2KbnHzqzubNFL3Drs-2NbMcpza_m2Sj-bvp4rN5SgtTScYB-CBw8CWQ09scS2-msThsB0OY5sWwWmmpa83gH1RgolKy0gP16JPqciolY_j5iIFZJmf-Jjcc7P_28UP_jkp8AJx-lDM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1701346548</pqid></control><display><type>article</type><title>Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Sahila, Mohammed Marunnan ; Babitha, Pallikkara Pulikkal ; Bandaru, Srinivas ; Nayarisseri, Anuraj ; Doss, Victor Arokia</creator><creatorcontrib>Sahila, Mohammed Marunnan ; Babitha, Pallikkara Pulikkal ; Bandaru, Srinivas ; Nayarisseri, Anuraj ; Doss, Victor Arokia ; Department of Biochemistry, PSG College of Arts and Science, Coimbatore - 641 014, India ; Department of Bioinformatics, SIAS-Centre for Scientific, Research, Safi Institute of Advanced Study(SIAS) , Rasiya Nagar, Vazhayoor East, Malappuram-673633, Kerala, India ; Bioinformatics Research Laboratory, Eminent Biosciences, Vijaynagar, Indore - 452010, India ; Department of Bioinformatics, School of Life Sciences, Karpagam University, Coimbatore 641021, India ; Research and Development centre, Bharathiyar University,Coimbatore.641046,Tamilnadu</creatorcontrib><description>The present antipsychotic drugs have known to show serious concerns like extra pyramidal side effects therefore, pursuit for novel antipsychotic GABAnergic drugs has lately focused on the folkloric medicine from plant derivatives as better treatment option of schizophrenia. The present study centers to identify potential inhibitors of plant origin for GABA receptor through in silico approaches. Three compound datasets were undertaken in the study. The first set consisted of seven compounds which included Magnolol, Honokiol and other plant derivatives. The second set consisted of 16 derivatives of N-diarylalkenyl-piperidinecarboxylic acid synthesized by Zheng et al., 2006. The third dataset had thirty two compounds which were Magnolol and Honokiol analogues synthesized by Fuchs et al., 2014. All the compounds were docked at the allosteric site of the GABA (A) receptor. The compounds were further tested for ADMET and biological activity. We observed Honokiol and its derivatives demonstrated superior druglike properties than any compound undertaken in the study. Further, compound 61 [2-(4-methoxyphenyl)-4-propylphenol] of dataset three - a synthetic derivative of honokiol had better profile than its parent compound. In a possible attempt to identify compound with even better efficacious compound than 61, virtual screening was performed, 135 compounds akin to compound 61 were retrieved. Interestingly none of the 135 compounds showed better druggable properties than compound 61. Our in silico pharmacological profiling of compounds is in coherence and is complemented by the findings of Fuchs et al, which also revealed compound 61 to be the good potentiator of GABA receptor. GABA (A) R - Gamma Amino Butyric Acid Receptor, subtype A, GPCR - G Protein Coupled Receptor, OPLS - Optimized Potentials for Liquid Simulations, PDB - Protein Data Bank, PLP - Piece wise Linear Potential, T.E.S.T - Toxicity Estimation Software Tool, TCM - Traditional Chinese Medicine.</description><identifier>ISSN: 0973-2063</identifier><identifier>ISSN: 0973-8894</identifier><identifier>EISSN: 0973-2063</identifier><identifier>DOI: 10.6026/97320630011280</identifier><identifier>PMID: 26229288</identifier><language>eng</language><publisher>Singapore: Biomedical Informatics</publisher><subject>Hypothesis</subject><ispartof>Bioinformation, 2015-01, Vol.11 (6), p.280-289</ispartof><rights>2015 Biomedical Informatics 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-5b8403ff62da8b4438a0de0d030aa2571d7d8fd9af23f4f2a6b158fee56ceac63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512002/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512002/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26229288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sahila, Mohammed Marunnan</creatorcontrib><creatorcontrib>Babitha, Pallikkara Pulikkal</creatorcontrib><creatorcontrib>Bandaru, Srinivas</creatorcontrib><creatorcontrib>Nayarisseri, Anuraj</creatorcontrib><creatorcontrib>Doss, Victor Arokia</creatorcontrib><creatorcontrib>Department of Biochemistry, PSG College of Arts and Science, Coimbatore - 641 014, India</creatorcontrib><creatorcontrib>Department of Bioinformatics, SIAS-Centre for Scientific, Research, Safi Institute of Advanced Study(SIAS) , Rasiya Nagar, Vazhayoor East, Malappuram-673633, Kerala, India</creatorcontrib><creatorcontrib>Bioinformatics Research Laboratory, Eminent Biosciences, Vijaynagar, Indore - 452010, India</creatorcontrib><creatorcontrib>Department of Bioinformatics, School of Life Sciences, Karpagam University, Coimbatore 641021, India</creatorcontrib><creatorcontrib>Research and Development centre, Bharathiyar University,Coimbatore.641046,Tamilnadu</creatorcontrib><title>Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives</title><title>Bioinformation</title><addtitle>Bioinformation</addtitle><description>The present antipsychotic drugs have known to show serious concerns like extra pyramidal side effects therefore, pursuit for novel antipsychotic GABAnergic drugs has lately focused on the folkloric medicine from plant derivatives as better treatment option of schizophrenia. The present study centers to identify potential inhibitors of plant origin for GABA receptor through in silico approaches. Three compound datasets were undertaken in the study. The first set consisted of seven compounds which included Magnolol, Honokiol and other plant derivatives. The second set consisted of 16 derivatives of N-diarylalkenyl-piperidinecarboxylic acid synthesized by Zheng et al., 2006. The third dataset had thirty two compounds which were Magnolol and Honokiol analogues synthesized by Fuchs et al., 2014. All the compounds were docked at the allosteric site of the GABA (A) receptor. The compounds were further tested for ADMET and biological activity. We observed Honokiol and its derivatives demonstrated superior druglike properties than any compound undertaken in the study. Further, compound 61 [2-(4-methoxyphenyl)-4-propylphenol] of dataset three - a synthetic derivative of honokiol had better profile than its parent compound. In a possible attempt to identify compound with even better efficacious compound than 61, virtual screening was performed, 135 compounds akin to compound 61 were retrieved. Interestingly none of the 135 compounds showed better druggable properties than compound 61. Our in silico pharmacological profiling of compounds is in coherence and is complemented by the findings of Fuchs et al, which also revealed compound 61 to be the good potentiator of GABA receptor. GABA (A) R - Gamma Amino Butyric Acid Receptor, subtype A, GPCR - G Protein Coupled Receptor, OPLS - Optimized Potentials for Liquid Simulations, PDB - Protein Data Bank, PLP - Piece wise Linear Potential, T.E.S.T - Toxicity Estimation Software Tool, TCM - Traditional Chinese Medicine.</description><subject>Hypothesis</subject><issn>0973-2063</issn><issn>0973-8894</issn><issn>0973-2063</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNUctKBDEQDKL4vnqUHPWw2kkmmexFWMUXKF4UvIVM0tHo7GRNZhf8e2fxgd48dXV3ddFFEbLH4EgBV8fjWnBQAoAxrmGFbMIwGS1Hq7_wBtkq5QWgYnUt18kGV5yPudab5PE2tejmrc3UJ_cauyfa2IKeFpcRu2WfAr2cnE7oweSQZnQ461OmsXuOTRxQoSGnKZ21tuupxxwXto8LLDtkLdi24O5X3SYPF-f3Z1ejm7vL67PJzcgJKfqRbHQFIgTFvdVNVQltwSN4EGAtlzXztdfBj23gIlSBW9UwqQOiVA6tU2KbnHzqzubNFL3Drs-2NbMcpza_m2Sj-bvp4rN5SgtTScYB-CBw8CWQ09scS2-msThsB0OY5sWwWmmpa83gH1RgolKy0gP16JPqciolY_j5iIFZJmf-Jjcc7P_28UP_jkp8AJx-lDM</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Sahila, Mohammed Marunnan</creator><creator>Babitha, Pallikkara Pulikkal</creator><creator>Bandaru, Srinivas</creator><creator>Nayarisseri, Anuraj</creator><creator>Doss, Victor Arokia</creator><general>Biomedical Informatics</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives</title><author>Sahila, Mohammed Marunnan ; Babitha, Pallikkara Pulikkal ; Bandaru, Srinivas ; Nayarisseri, Anuraj ; Doss, Victor Arokia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-5b8403ff62da8b4438a0de0d030aa2571d7d8fd9af23f4f2a6b158fee56ceac63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Hypothesis</topic><toplevel>online_resources</toplevel><creatorcontrib>Sahila, Mohammed Marunnan</creatorcontrib><creatorcontrib>Babitha, Pallikkara Pulikkal</creatorcontrib><creatorcontrib>Bandaru, Srinivas</creatorcontrib><creatorcontrib>Nayarisseri, Anuraj</creatorcontrib><creatorcontrib>Doss, Victor Arokia</creatorcontrib><creatorcontrib>Department of Biochemistry, PSG College of Arts and Science, Coimbatore - 641 014, India</creatorcontrib><creatorcontrib>Department of Bioinformatics, SIAS-Centre for Scientific, Research, Safi Institute of Advanced Study(SIAS) , Rasiya Nagar, Vazhayoor East, Malappuram-673633, Kerala, India</creatorcontrib><creatorcontrib>Bioinformatics Research Laboratory, Eminent Biosciences, Vijaynagar, Indore - 452010, India</creatorcontrib><creatorcontrib>Department of Bioinformatics, School of Life Sciences, Karpagam University, Coimbatore 641021, India</creatorcontrib><creatorcontrib>Research and Development centre, Bharathiyar University,Coimbatore.641046,Tamilnadu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioinformation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sahila, Mohammed Marunnan</au><au>Babitha, Pallikkara Pulikkal</au><au>Bandaru, Srinivas</au><au>Nayarisseri, Anuraj</au><au>Doss, Victor Arokia</au><aucorp>Department of Biochemistry, PSG College of Arts and Science, Coimbatore - 641 014, India</aucorp><aucorp>Department of Bioinformatics, SIAS-Centre for Scientific, Research, Safi Institute of Advanced Study(SIAS) , Rasiya Nagar, Vazhayoor East, Malappuram-673633, Kerala, India</aucorp><aucorp>Bioinformatics Research Laboratory, Eminent Biosciences, Vijaynagar, Indore - 452010, India</aucorp><aucorp>Department of Bioinformatics, School of Life Sciences, Karpagam University, Coimbatore 641021, India</aucorp><aucorp>Research and Development centre, Bharathiyar University,Coimbatore.641046,Tamilnadu</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives</atitle><jtitle>Bioinformation</jtitle><addtitle>Bioinformation</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>11</volume><issue>6</issue><spage>280</spage><epage>289</epage><pages>280-289</pages><issn>0973-2063</issn><issn>0973-8894</issn><eissn>0973-2063</eissn><abstract>The present antipsychotic drugs have known to show serious concerns like extra pyramidal side effects therefore, pursuit for novel antipsychotic GABAnergic drugs has lately focused on the folkloric medicine from plant derivatives as better treatment option of schizophrenia. The present study centers to identify potential inhibitors of plant origin for GABA receptor through in silico approaches. Three compound datasets were undertaken in the study. The first set consisted of seven compounds which included Magnolol, Honokiol and other plant derivatives. The second set consisted of 16 derivatives of N-diarylalkenyl-piperidinecarboxylic acid synthesized by Zheng et al., 2006. The third dataset had thirty two compounds which were Magnolol and Honokiol analogues synthesized by Fuchs et al., 2014. All the compounds were docked at the allosteric site of the GABA (A) receptor. The compounds were further tested for ADMET and biological activity. We observed Honokiol and its derivatives demonstrated superior druglike properties than any compound undertaken in the study. Further, compound 61 [2-(4-methoxyphenyl)-4-propylphenol] of dataset three - a synthetic derivative of honokiol had better profile than its parent compound. In a possible attempt to identify compound with even better efficacious compound than 61, virtual screening was performed, 135 compounds akin to compound 61 were retrieved. Interestingly none of the 135 compounds showed better druggable properties than compound 61. Our in silico pharmacological profiling of compounds is in coherence and is complemented by the findings of Fuchs et al, which also revealed compound 61 to be the good potentiator of GABA receptor. GABA (A) R - Gamma Amino Butyric Acid Receptor, subtype A, GPCR - G Protein Coupled Receptor, OPLS - Optimized Potentials for Liquid Simulations, PDB - Protein Data Bank, PLP - Piece wise Linear Potential, T.E.S.T - Toxicity Estimation Software Tool, TCM - Traditional Chinese Medicine.</abstract><cop>Singapore</cop><pub>Biomedical Informatics</pub><pmid>26229288</pmid><doi>10.6026/97320630011280</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-2063
ispartof Bioinformation, 2015-01, Vol.11 (6), p.280-289
issn 0973-2063
0973-8894
0973-2063
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4512002
source EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access
subjects Hypothesis
title Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A19%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20docking%20based%20screening%20of%20GABA%20(A)%20receptor%20inhibitors%20from%20plant%20derivatives&rft.jtitle=Bioinformation&rft.au=Sahila,%20Mohammed%20Marunnan&rft.aucorp=Department%20of%20Biochemistry,%20PSG%20College%20of%20Arts%20and%20Science,%20Coimbatore%20-%20641%20014,%20India&rft.date=2015-01-01&rft.volume=11&rft.issue=6&rft.spage=280&rft.epage=289&rft.pages=280-289&rft.issn=0973-2063&rft.eissn=0973-2063&rft_id=info:doi/10.6026/97320630011280&rft_dat=%3Cproquest_pubme%3E1701346548%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1701346548&rft_id=info:pmid/26229288&rfr_iscdi=true